Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

GLOSTER unleashes Dry Fog on nosocomial agents

18.10.2004


GLOSTER SANTE EUROPE of France will be presenting its unique, complementary solution for preventing and treating nosocomial infections using Dry Fog diffusion technology at the Düsseldorf trade fair in late November. This innovative, patented technology is underpinned by the STERINIS(r)/STERUSIL(r) device/product pair. It is used to disinfect all kinds of surfaces, including those which are generally inaccessible or hidden in a hospital/patient environment or in other ultra-sensitive environments (such as mass catering facilities, day nurseries and other public places).

... mehr zu:
»Dry »Europe »Fog »GLOSTER »SANTE »STERINIS

Nosocomial infections (i.e. those that originate or occur in a hospital or hospital-like setting) are a recognized and critical problem worldwide. Methods of disinfection currently available commercially (directed spray, nebulisation, wet spray, etc.) are not effective enough and cannot be used to diffuse and apply disinfectant products in all areas and on all surfaces (including medical devices and equipment). As a result, infectious agents can quickly re-contaminate the area that is affected.

In France, statistics vary (depending on sources), but it is estimated that between 6,000 and 10,000 patients die every year from the consequences of nosocomial infections. Across Europe, the number of such deaths is estimated to be about 90,000 per annum. If anything, the situation is getting worse: previously encountered essentially in a hospital environment, infections of this kind have now started to affect all places frequented by the public.


With these issues in mind, GLOSTER SANTE EUROPE has developed Dry Fog, a dedicated technology and a complete innovation, ensuring the perfect and even diffusion of the disinfectant throughout the area and on all the surfaces treated - including those which are normally inaccessible or hidden. This diffusion system provides a mist-like aerosol quality (with a droplet size of 8µ to 12µ) to the spreading of the disinfectant, with electrically charged droplets that promote nucleation.

The STERINIS(r)/STERUSIL(r) device/product pair makes Dry Fog possible. STERINIS(r), which is a mobile and easy-to-handle system, is used with STERUSIL(r) disinfectant. The disinfectant is non-toxic, non-corrosive, biodegradable, prepared in two-litre cartridges, electronically identifiable, tamper-proof and disposable. STERINIS(r)/STERUSIL(r) is already being distributed in 20 countries via a comprehensive distribution network.

The STERINIS(r)/STERUSIL(r) process is the answer to the ’missing link’ in the disinfection chain. It can be included as a natural stage in the general hygiene process, and considerably reduces the concentration of germs by limiting the risks of human error (especially those generated by forgetfulness on the part of staff). Based on leading-edge Dry Fog diffusion technology, STERINIS(r) is designed for use in all medical sectors and service industries concerned by disinfection.

GLOSTER SANTE EUROPE’s innovative solution also has other advantages. The STERINIS(r) device guarantees perfect traceability via a patented data recording system, while the cartridges of STERUSIL(r) disinfectant are tamper-proof (being protected by electronic detection technology) and easy to use (thanks to programmable parameters). The STERINIS(r) device verifies the conformity of the disinfection process and runs automatic checking procedures (check-up, amount of disinfectant diffused, quality of the misting process, etc.). Besides, STERINIS(r) does not require personnel intervention and rooms can be used very quickly after they have been treated.

The STERINIS(r)/STERUSIL(r) process has already been successfully tested under actual conditions of application in a hospital environment (operating theatres, recovery rooms, rooms used for infectious patients, etc.). It meets all harmonized standards currently applicable and European Union directives (73/23/CE, 98/68/CE, 89/336/CE, NFT 72-281, NF EN 55011, and NF EN 55022). GLOSTER SANTE EUROPE has been ISO-certified (ISO 9001 & ISO 13485) by SGS YARKLEY (UKAS).

About GLOSTER SANTE EUROPE

GLOSTER SANTE EUROPE will present the STERINIS(r) system at the MEDICA trade fair, which will be taking place in Düsseldorf (Germany) from 20 to 23 November 2004.

GLOSTER SANTE EUROPE, which is headquartered in Toulouse (in South-Western France), designs, manufactures and distributes equipment and technologies that guarantee the comprehensive and effective disinfection of surfaces in the medical sector, in the pharmaceutical industry, and in any field of activity where disinfection is a concern (which includes public places, airliners, industrial installations and farming equipment). About 80% of the company’s sales are generated by exports.

Philip JOLLY | FTPB - press
Weitere Informationen:
http://www.gloster-sante-europe.com
http://www.infotechfrance.com/london

Weitere Berichte zu: Dry Europe Fog GLOSTER SANTE STERINIS

Weitere Nachrichten aus der Kategorie Messenachrichten:

nachricht Digitalisierung von HR-Prozessen – tisoware auf der Personal Nord und Süd
21.03.2017 | tisoware Gesellschaft für Zeitwirtschaft mbH

nachricht Hochauflösende Laserstrukturierung dünner Schichten auf der LOPEC 2017
21.03.2017 | Fraunhofer-Institut für Lasertechnik ILT

Alle Nachrichten aus der Kategorie: Messenachrichten >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fliegende Intensivstationen: Ultraschallgeräte in Rettungshubschraubern können Leben retten

Etwa 21 Millionen Menschen treffen jährlich in deutschen Notaufnahmen ein. Im Kampf zwischen Leben und Tod zählt für diese Patienten jede Minute. Wenn sie schon kurz nach dem Unfall zielgerichtet behandelt werden können, verbessern sich ihre Überlebenschancen erheblich. Damit Notfallmediziner in solchen Fällen schnell die richtige Diagnose stellen können, kommen in den Rettungshubschraubern der DRF Luftrettung und zunehmend auch in Notarzteinsatzfahrzeugen mobile Ultraschallgeräte zum Einsatz. Experten der Deutschen Gesellschaft für Ultraschall in der Medizin e.V. (DEGUM) schulen die Notärzte und Rettungsassistenten.

Mit mobilen Ultraschallgeräten können Notärzte beispielsweise innere Blutungen direkt am Unfallort identifizieren und sie bei Bedarf auch für Untersuchungen im...

Im Focus: Gigantische Magnetfelder im Universum

Astronomen aus Bonn und Tautenburg in Thüringen beobachteten mit dem 100-m-Radioteleskop Effelsberg Galaxienhaufen, das sind Ansammlungen von Sternsystemen, heißem Gas und geladenen Teilchen. An den Rändern dieser Galaxienhaufen fanden sie außergewöhnlich geordnete Magnetfelder, die sich über viele Millionen Lichtjahre erstrecken. Sie stellen die größten bekannten Magnetfelder im Universum dar.

Die Ergebnisse werden am 22. März in der Fachzeitschrift „Astronomy & Astrophysics“ veröffentlicht.

Galaxienhaufen sind die größten gravitativ gebundenen Strukturen im Universum, mit einer Ausdehnung von etwa zehn Millionen Lichtjahren. Im Vergleich dazu ist...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Auf der Spur des linearen Ubiquitins

Eine neue Methode ermöglicht es, den Geheimcode linearer Ubiquitin-Ketten zu entschlüsseln. Forscher der Goethe-Universität berichten darüber in der aktuellen Ausgabe von "nature methods", zusammen mit Partnern der Universität Tübingen, der Queen Mary University und des Francis Crick Institute in London.

Ubiquitin ist ein kleines Molekül, das im Körper an andere Proteine angehängt wird und so deren Funktion kontrollieren und verändern kann. Die Anheftung...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Lebenswichtige Lebensmittelchemie

23.03.2017 | Veranstaltungen

Die „Panama Papers“ aus Programmierersicht

22.03.2017 | Veranstaltungen

Über Raum, Zeit und Materie

22.03.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Besser lernen dank Zink?

23.03.2017 | Biowissenschaften Chemie

Lebenswichtige Lebensmittelchemie

23.03.2017 | Veranstaltungsnachrichten

Innenraum-Ortung für dynamische Umgebungen

23.03.2017 | Architektur Bauwesen